We have provided a critical assessment of research on the reduction of cholesterol levels by
statin treatment to reduce cardiovascular disease. Our opinion is that although statins are
effective at reducing cholesterol levels, they have failed to substantially improve cardiovascular
outcomes.
We have described the deceptive approach statin advocates have deployed to
create the appearance that cholesterol reduction results in an impressive reduction in
cardiovascular disease outcomes through their use of a statistical tool called relative risk
reduction (RRR), a method which amplifies the trivial beneficial effects of statins. We have
also described how the directors of the clinical trials have succeeded in minimizing the
significance of the numerous adverse effects of statin treatment.
Read more
No comments:
Post a Comment